CONMED Corporation to Announce Third Quarter 2022 Financial Results on October 26, 2022
CONMED Corporation (NYSE: CNMD) will release its third-quarter 2022 financial results on October 26, 2022, post market close. A conference call to discuss the results will take place at 4:30 p.m. ET on the same day. Interested parties can participate via telephone by pre-registering online or access the webcast from CONMED's website, with a replay available after the call.
CONMED specializes in medical technology, providing surgical devices for minimally invasive procedures across various specialties.
- None.
- None.
To participate in the conference call via telephone, please click here to pre-register and obtain the dial-in number and passcode.
This conference call will also be webcast and can be accessed from the “Investors” section of CONMED's website at www.conmed.com. The webcast replay of the call will be available at the same site approximately one hour after the end of the call.
About
CONMED is a medical technology company that provides surgical devices and equipment for minimally invasive procedures. The Company’s products are used by surgeons and physicians in a variety of specialties, including orthopedics, general surgery, gynecology, thoracic surgery, and gastroenterology. For more information, visit www.conmed.com.
Forward-Looking Statements
This press release and the associated conference call may contain forward-looking statements based on certain assumptions and contingencies that involve risks and uncertainties, which could cause actual results, performance, or trends to differ materially from those expressed in the forward-looking statements herein or in previous disclosures. For example, in addition to general industry and economic conditions, factors that could cause actual results to differ materially from those in the forward-looking statements may include, but are not limited to, the risks posed to the Company’s business, financial condition, and results of operations by the COVID-19 global pandemic and the various government and other responses to the pandemic, including deferral of surgeries, reductions in hospital and ambulatory surgery center operating volumes, disruption to potential supply chain reliability, as well as the risk factors discussed in the Company's Annual Report on Form 10-K for the full year ended
View source version on businesswire.com: https://www.businesswire.com/news/home/20221010005530/en/
Chief Financial Officer
727-214-2975
ToddGarner@conmed.com
Source:
FAQ
When will CONMED Corporation announce its Q3 2022 financial results?
What time is CONMED's Q3 2022 conference call?
How can I listen to CONMED's Q3 2022 earnings call?